May 3, 2016

Chicago Tribune

The Blues Singer Who Created America’s Hated Drug-Pricing Model

By Robert Langreth and Zachary Tracer

While Mick Kolassa may be a household name to hard-core blues lovers, he’s hardly one to the patients and politicians who complain about avaricious drug companies. But long before 2014’s “Michissippi Mick,” his first album, Kolassa helped revolutionize the way the industry decides what to charge, and how it justifies commanding premiums for game-changing remedies.

read full article >